EastHORN – A Novotech Company will be present this year at the BioTrinity 2023 Conference in London
EastHORN – A Novotech Company will be present this year at the BioTrinity 2023 Conference – sponsored by Novotech
The event will bring together biotech leaders, investors, innovators, and great speakers from around the world to focus on “catalyzing growth in the life sciences industry”.
Jan Rezulski, Director of Business Development – Europe, will team up with Novotech’s Nick Rich, Regional Director of Business Development, and David Chia, Senior Business Development Manager, to secure a one-on-one partnering meeting to discuss how EastHORN’s and Novotech’s experience and expertise can add value to your programme.
- Laverage Australia’s 43.5% tax rebate and rapid start-up
- Access Europe as well as Asia and Australia’s large patient pools and extensive site networks
- Engage with Novotech’s Drug Development Consulting expertise and equity funding model to support getting through clinical development as quickly and as efficiently as possible on a global scale
- Take advantage of our Clinical Trial Information System (CTIS) expertise, which helps to support the flow of information between EU Member States, European Economic Area (EEA) countries, and the European Commission
Click on the link below and book a meeting. We look forward to learning more about your clinical development needs and exploring potential collaborations in 2023.